A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
Noëlle Warmenhoven(Malmö University), Oskar Hansson(Lund University), Alexa Pichet Binette(Lund University), Divya Bali(Malmö University), Randall J. Bateman(Washington University in St. Louis), Kaj Blennow(Sahlgrenska University Hospital), Carlos Cruchaga(Washington University in St. Louis), Niklas Mattsson(Lund University), Burak Arslan(University of Gothenburg), Anna Orduña Dolado(Malmö University), Gemma Salvadó(Lund University), Cyrus A. Raji(Washington University in St. Louis), Gallen Triana‐Baltzer(Pfizer (United States)), Nicolas R. Barthélemy(Washington University in St. Louis), Hartmuth C. Kolb(Johnson & Johnson (United States)), Laura Ibáñez(Washington University in St. Louis), Suzanne E. Schindler(Meharry Medical College), Henrik Zetterberg(Queen Mary University of London), Andrew J. Aschenbrenner(Washington University in St. Louis), Jigyasha Timsina(Washington University in St. Louis), Tammie L.S. Benzinger(Washington University in St. Louis), Shorena Janelidze(Lund University), Nicholas J. Ashton(Alzheimer's Association)
Cited by 95
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k